SINO BIOPHARMACEUTICAL LIMITED (08027)
| Auditor | From | To | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|
| McMillan Woods HK | 03-Jan-22 | |||
| HLB Hodgson Impey Cheng | 22-Dec-17 | 03-Jan-22 | Could not reach a consensus on the audit fee for the financial year ended 31 December 2021. | |
| Deloitte Singapore | 30-Jun-15 | 21-Dec-17 | Historical transition (details not available in archive) |